Cefiderocol for Intravenous Drip Infusion 1g (Fetroja® / フェトロージャ点滴静注用1g)

JPY ¥262,600

Japanese Siderophore Cephalosporin Antibacterial Agent (Cefiderocol Tosilate Sulfate Hydrate 1g). For intravenous drip infusion in the treatment of various infections caused by carbapenem-resistant Gram-negative bacteria. 10 vials [1g x 10]. Mfd. by Shionogi & Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥241,592
10 - 19 12% JPY ¥231,088
20 + 18% JPY ¥215,332
SKU: FTR-1-INJ Category:

Description

Product Overview / 商品概要

Fetroja for Intravenous Drip Infusion 1g (フェトロージャ点滴静注用1g)
Generic: Cefiderocol Tosilate Sulfate Hydrate / セフィデロコルトシル酸塩硫酸塩水和物
Therapeutic Category: Siderophore Cephalosporin Antibacterial Agent / シデロフォアセファロスポリン系抗生物質製剤
Manufactured by: Shionogi & Co., Ltd. / 塩野義製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Cefiderocol 1g per vial / 1瓶中セフィデロコルとして1g
Additives: Purified sucrose 900.0mg, Sodium chloride 216.0mg, Sodium hydroxide / 精製白糖 900.0mg、塩化ナトリウム 216.0mg、水酸化ナトリウム
Appearance: White, light lump or powder (injection); pH 5.2–5.8; Osmolarity ratio (relative to physiological saline) 1.4–2.0
外観: 白色の軽質の塊又は粉末(注射剤)、pH 5.2~5.8、浸透圧比(生理食塩液に対する比)1.4~2.0

Indications / 効能効果

EN: Susceptible strains of: Escherichia coli, Citrobacter spp., Klebsiella pneumoniae, Klebsiella spp., Enterobacter spp., Serratia marcescens, Proteus spp., Morganella morganii, Pseudomonas aeruginosa, Burkholderia spp., Stenotrophomonas maltophilia, Acinetobacter spp. — limited to strains resistant to carbapenem antibacterials. Indication: Various infections.
JA: 〈適応菌種〉セフィデロコルに感性の大腸菌、シトロバクター属、肺炎桿菌、クレブシエラ属、エンテロバクター属、セラチア・マルセスセンス、プロテウス属、モルガネラ・モルガニー、緑膿菌、バークホルデリア属、ステノトロホモナス・マルトフィリア、アシネトバクター属。ただし、カルバペネム系抗菌薬に耐性を示す菌株に限る。〈適応症〉各種感染症

Dosage and Administration / 用法用量

EN: Usually, in adults, administer cefiderocol 2g every 8 hours as a 3-hour intravenous drip infusion. Adjust dose according to renal function.
JA: 通常、成人には、セフィデロコルとして1回2gを8時間ごとに3時間かけて点滴静注する。なお、腎機能に応じて適宜増減する。

Contraindications / 禁忌

EN: 2.1 Patients with a history of serious hypersensitivity to any component of this product. 2.2 Patients with a history of serious hypersensitivity (e.g., anaphylaxis or severe systemic allergic reactions) to other beta-lactam antibiotics.
JA: 2.1 本剤の成分に対し重篤な過敏症の既往歴のある患者 2.2 他のβ-ラクタム系抗生物質に対し重篤な過敏症(アナフィラキシー等の重度の全身性アレルギー反応)の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 30500AMX00283000
Sales Started: December 2023 / 2023年12月
Classification Code: 876129
Storage: Store at 2–8°C / 2~8℃で保存
Shelf Life: 5 years / 5年

Packaging / 包装

Main Package (for sale): 10 vials [1g x 10] / 10瓶[1g×10]
Other Available Packages (by special order): 10 vials [1g x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Cefiderocol for Intravenous Drip Infusion 1g (Fetroja® / フェトロージャ点滴静注用1g)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Cefiderocol for Intravenous Drip Infusion 1g (Fetroja®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.